The IPO Buzz: Biotech Septerna Prices Upsized IPO at $18 & Stock Climbs on NASDAQ
Septerna Inc. (SEPN), a thyroid-focused Phase I biotech, upsized its IPO at pricing to 16.0 million shares – up from 15.28 million shares in the recently upsized prospectus – and priced the IPO at $18.00 – as planned – to raise $288.0 million on Thursday night, Oct. 24, 2024. Septerna’s stock opened at $23.50 – up […]
October 25, 2024 Read More